Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organon
MedTech
Organon divests Jada System, sends 100 employees to Laborie
Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical Technologies in a deal worth up to $465 million.
Ben Adams
Nov 7, 2025 9:05am
Prominent vaccine critic ousted from HHS—Chutes & Ladders
Oct 31, 2025 8:30am
Organon axes 'biggest potential opportunity' after trial fail
Jul 2, 2025 8:43am
Organon to work with White House on women's health research: CEO
Nov 15, 2023 10:41am
Organon touts real-world win of its postpartum hemorrhage device
Sep 18, 2023 11:25am
Bayer deprioritizes women's health R&D
Mar 24, 2023 2:40pm
